Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

YOICHI HAMAI; MANABU EMI; YUTA IBUKI; YUJI MURAKAMI; IKUNO NISHIBUCHI; YASUSHI NAGATA; TAKAOKI FURUKAWA; TOMOAKI KUROKAWA; MANATO OHSAWA; MORIHITO OKADA

doi:10.21873/anticanres.13259

Research ArticleClinical Studies

Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA and MORIHITO OKADA

Anticancer Research March 2019, 39 (3) 1433-1440; DOI: https://doi.org/10.21873/anticanres.13259

YOICHI HAMAI

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: yyhamai{at}hotmail.com

MANABU EMI

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUTA IBUKI

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUJI MURAKAMI

2Department of Radiation Oncology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

IKUNO NISHIBUCHI

2Department of Radiation Oncology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YASUSHI NAGATA

2Department of Radiation Oncology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKAOKI FURUKAWA

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TOMOAKI KUROKAWA

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MANATO OHSAWA

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MORIHITO OKADA

1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 39 no. 3 1433-1440

DOI

https://doi.org/10.21873/anticanres.13259

PMID

30842179

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received January 28, 2019
Revision received February 16, 2019
Accepted February 21, 2019
Published online March 6, 2019.

Author Information

YOICHI HAMAI¹ ⇑,
MANABU EMI¹,
YUTA IBUKI¹,
YUJI MURAKAMI²,
IKUNO NISHIBUCHI²,
YASUSHI NAGATA²,
TAKAOKI FURUKAWA¹,
TOMOAKI KUROKAWA¹,
MANATO OHSAWA¹ and
MORIHITO OKADA¹

¹Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
²Department of Radiation Oncology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Correspondence to: Yoichi Hamai, MD, Ph.D., Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan. Tel: +81 822575869, Fax: +81 822567109, e-mail: yyhamai{at}hotmail.com

View Full Text

Statistics from Altmetric.com

Cited By...

32 Citations
Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext

In this issue

Anticancer Research

Vol. 39, Issue 3

March 2019

Table of Contents
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 1 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA, MORIHITO OKADA

Anticancer Research Mar 2019, 39 (3) 1433-1440; DOI: 10.21873/anticanres.13259

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA, MORIHITO OKADA

Anticancer Research Mar 2019, 39 (3) 1433-1440; DOI: 10.21873/anticanres.13259

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma
Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy
Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy
A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation

Google Scholar

Keywords

chemoradiation
Complication
Esophagus
lymph node
vascular invasion

Main menu

User menu

Search

Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords